Current trials in erythropoietic protoporphyria: are placebo controls ethical? [PDF]
Orphanet J Rare Dis, 2023 Barman-Aksözen J +2 more
europepmc +1 more source
Editorial: Melanocortins and melanocortin receptors in the regulation of inflammation: mechanisms and novel therapeutic strategies. [PDF]
, 2023 Montero-Melendez, T +2 more
core +1 more source
Illuminating Dersimelagon: A Novel Agent in the Treatment of Erythropoietic Protoporphyria and X-Linked Protoporphyria. [PDF]
Pharmaceuticals (Basel), 2023 Madigan KE +4 more
europepmc +1 more source
Quality-Adjusted Life Years in Erythropoietic Protoporphyria and Other Rare Diseases: A Patient-Initiated EQ-5D Feasibility Study. [PDF]
Int J Environ Res Public Health, 2023 Barman-Aksözen J +6 more
europepmc +1 more source
Tanning Melanotan Jabs and Nasal Spray: Safe or Not? [PDF]
Cultural values among young population are focused on the concept of skin tanning as a perception of health and attractiveness. This has populated the development of using synthetic tanning agents especially with the advertisement coming from the social ...
Al Abadie, Mohammed +2 more
core
Burden of illness and unmet needs in patients with erythropoietic protoporphyria and X-linked protoporphyria: A large US nationwide claims analysis. [PDF]
J Manag Care Spec PharmDerSarkissian M +7 more
europepmc +1 more source
Wetenschappelijk onderzoek in België : een nieuw scoresysteem voor de beoordeling van vitiligo en inzichten op gebied van therapie [PDF]
, 2016 Speeckaert, Reinhart, van Geel, Nanja
core +1 more source
Development and content validation of a sunlight exposure diary in patients with erythropoietic protoporphyria. [PDF]
J Patient Rep Outcomes, 2023 Mathias SD +5 more
europepmc +1 more source